Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide

Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy

(2010) Pierpaolo Correale et al.   JOURNAL OF IMMUNOTHERAPY

DC therapy induces long-term NK reactivity to tumors via host DC

(2009) Kanako Shimizu et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties

(2009) Sébastien Anguille et al.   Journal of Translational Medicine

Reengineering dendritic cell-based anti-cancer vaccines

(2008) Gary K. Koski et al.   IMMUNOLOGICAL REVIEWS

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

(2008) Paul Salama et al.   JOURNAL OF CLINICAL ONCOLOGY

Combined use of toll-like receptor agonists and prostaglandin E2 in the FastDC model: Rapid generation of human monocyte-derived dendritic cells capable of migration and IL-12p70 production

(2008) Marc Dauer et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Therapeutic Dendritic Cell Vaccination of Patients With Metastatic Renal Cell Carcinoma

(2008) Annika Berntsen et al.   JOURNAL OF IMMUNOTHERAPY

Clinical Grade OK432-activated Dendritic Cells

(2008) Emma West et al.   JOURNAL OF IMMUNOTHERAPY

Memory T cells in cancer immunotherapy: which CD8+T-cell population provides the best protection against tumours?

(2008) R. Perret et al.   TISSUE ANTIGENS